September 10, 2008
Article
Second-Generation Long-Acting Injectables Significantly Improve Long-Term Severe Schizophrenia Outcomes
Wonder Drake, MD: Sarcoidosis is a Disease of Exclusion
FDA Approves Dupilumab for Eosinophilic Esophagitis